By conducting a systematic review summarizing available evidence of IDH‐induced effects on the immunogenicity of IDH‐mutant glioma, three main mechanisms were identified; namely, (a) epigenetic, (b) metabolic, and (c) paracrine. This evidence concerns the gene IDH2 and central nervous system cancer.